Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (Parentheticals)

v3.7.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (Parentheticals) - USD ($)
3 Months Ended 6 Months Ended
Apr. 30, 2017
Apr. 30, 2016
Apr. 30, 2017
Apr. 30, 2016
Research and Development Expense [Member]        
Non-cash Stock Option Compensation Expenses $ 68,928 $ 72,496 $ 148,628 $ 91,442
Selling and Marketing Expense [Member]        
Non-cash Stock Option Compensation Expenses $ 122,991 $ 144,758 $ 303,028 $ 238,307